当前位置: X-MOL 学术Ann. Rheum. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya
Annals of the Rheumatic Diseases ( IF 20.3 ) Pub Date : 2022-03-01 , DOI: 10.1136/annrheumdis-2020-217282
Alexis Mathian 1 , Micheline Pha 1 , Zahir Amoura 2
Affiliation  

We thank Acharya for her interest in our study showing that in patients with systemic lupus erythematosus (SLE) with a quiescent disease and a stable treatment regimen, for at least 1 year, withdrawal of 5 mg of prednisone was associated with a fourfold increase (ie, 27%), in the risk of flare onset, as defined by the SELENA-SLEDAI flare index and the British Isles Lupus Assessment Group index during a 1-year follow-up.1 2 Acharya states that these findings contrast with those from two previous published studies on the same subject.3 4 The latter studies are, however, not comparable …

中文翻译:

回应:“狼疮中的糖皮质激素戒断:做还是不做?” 通过 Acharya

我们感谢 Acharya 对我们研究的兴趣,该研究表明,在患有静止期疾病和稳定治疗方案的系统性红斑狼疮 (SLE) 患者中,至少 1 年,停用 5 mg 泼尼松与四倍增加相关(即, 27%),根据 SELENA-SLEDAI 耀斑指数和不列颠群岛狼疮评估组指数在 1 年随访期间的定义。1 2 Acharya 指出,这些发现与来自两个以前发表的关于同一主题的研究。3 4 然而,后面的研究没有可比性……
更新日期:2022-02-14
down
wechat
bug